本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.41
-0.6700-5.55%
成交量:14.41萬
成交額:164.81萬
市值:3.91億
市盈率:-12.22
高:12.12
開:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49萬
流通股本:1,792.50萬
量比:2.26
換手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
淨資產收益率:-29.58%
總資產收益率:-19.93%
市淨率:2.13
市盈率(LYR):-10.90

資料載入中...

2021/04/29

重要事件披露

8-K - Current report
2021/04/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/28

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/27

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/24

重要事件披露

8-K - Current report
2021/02/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/19

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/15

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/03

重要事件披露

8-K - Current report